Finance

Lists
Why is TECX down 2,66%?
Dive Deeper
TECX:NASDAQ
Tectonic Therapeutic Inc
USD 22,67
-2,66%
(-0,62) 1D
USD 23,00
+1,46% (+0,33)
After hours
Closed: 1 Okt., 16:00:00 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for TECX...
Open
USD 23,25
High
USD 23,65
Low
USD 22,41
Mkt. cap
443,18 m
Avg. vol.
235,52 k
Volume
343,51 k
52-wk high
USD 39,53
52-wk low
USD 14,62
EPS
-USD 4,56
Beta
1,26
Shares outstanding
19,55 m
No. of employees
60
Open
USD 23,25
High
USD 23,65
Low
USD 22,41
Mkt. cap
443,18 m
Avg. vol.
235,52 k
Volume
343,51 k
52-wk high
USD 39,53
52-wk low
USD 14,62
EPS
-USD 4,56
Beta
1,26
Shares outstanding
19,55 m
No. of employees
60
News stories
From web sources and news partners
About Tectonic Therapeutic Inc
CEO-
Employees60
Founded2019
HeadquartersWatertown, Massachusetts, Verenigde State van Amerika
Sector-
Websitetectonictx.com
Analyst ratings
Based on 6 analysts giving stock ratings to TECX in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for TECX in the last 3 months.
Highest
Current USD 22,67
USD 93,00 (+310,23%)
Average
USD 78,67 (+247,02%)
Lowest
USD 60,00 (+164,67%)
Analyst
Recommendation
Action
Price target
Projected
Date
James Condulis
Stifel Nicolaus
Buy
Maintained
USD 75,00
+230,8%
10/01/2026
Yasmeen Rahimi
Piper Sandler
Buy
Maintained
USD 76,00
+235,2%
09/30/2026
Benjamin Burnett
Wells Fargo
Buy
Reiterated
USD 93,00
+310,2%
09/29/2026
Gaurav Maini
LifeSci Capital
Buy
Maintained
USD 88,00
+288,2%
09/29/2026
Unknown Analyst
Oppenheimer
Buy
Reiterated
USD 80,00
+252,9%
09/01/2026
Uy Ear
Mizuho Securities
Buy
Reiterated
USD 85,00
+274,9%
08/27/2026
Danielle Brill
Truist Financial
Buy
Maintained
USD 60,00
+164,7%
08/10/2026
Martin Auster
Raymond James
Buy
Maintained
USD 81,00
+257,3%
05/26/2026
Tyler Van Buren
TD Cowen
Buy
Maintained
-
-
05/08/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
16,93 m
16,34 m
20,87 m
18,05 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
4,96 m
5,18 m
6,43 m
6,17 m
Operating expense
21,89 m
21,52 m
27,30 m
24,22 m
Total operating expenses
21,89 m
21,52 m
27,30 m
24,22 m
Operating income
-21,89 m
-21,52 m
-27,30 m
-24,22 m
Other non operating income
-31,00 k
-8,00 k
-113,00 k
-5,00 k
EBT including unusual items
-19,04 m
-18,97 m
-25,24 m
-22,21 m
EBT excluding unusual items
-19,04 m
-18,97 m
-25,24 m
-22,21 m
Income tax expense
-
254,00 k
-
77,00 k
Effective tax rate
-
-1,34%
-
-0,35%
Other operating expenses
-
-
-
-
Net income
-19,04 m
-19,23 m
-25,24 m
-22,28 m
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
2,90 m
2,56 m
2,18 m
2,02 m
Interest expense
-14,00 k
-12,00 k
-8,00 k
-6,00 k
Net interest expenses
2,89 m
2,55 m
2,17 m
2,02 m
Depreciation and amortization charges
-
-
-
-
EBITDA
-21,55 m
-21,18 m
-27,00 m
-23,93 m
Gain or loss from assets sale
93,00 k
-
23,00 k
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme